Navigation

Information for patients: Guidance on the use of paclitaxel in the treatment of ovarian cancer

This is patient's leaflet on the use of paclitaxel in the treatment of ovarian cancer.

Some advice on using paclitaxel for re-challenge therapy and the second-line treatment of advanced ovarian cancer has been replaced by NICE technology appraisal guidance 91. See TA91 (www.nice.org.uk/guidance/TA91) for more details.

This page was last updated: 12 November 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.